Kiromic BioPharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$21,294,000 over the previous period. Total operating expenses were $19,939,300.
Profit Margin
| 2018 | 0 | -3.81M | |
|---|---|---|---|
| 2019 | 0 | -3.75M | |
| 2020 | 0 | -19.20M | |
| 2021 | 0 | -25.65M | |
| 2022 | 0 | -38.18M | |
| 2023 | 0 | -21.29M |
KRBP Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 2.79M | 0 | 0 | 200K | 0 | 0 |
Gross profit | -2.79M | 0 | 0 | -200K | 0 | 0 |
Operating exp. | ||||||
Research and development | 9.62M | 13.92M | 11.36M | 5.05M | 1.20M | 1.42M |
Selling and marketing | -2.79M | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 19.93M | 31.11M | 25.30M | 19.19M | 3.70M | 3.18M |
Operating income | -19.93M | -31.11M | -25.73M | -19.19M | -3.70M | -3.18M |
Other income (expenses), net | -1.01M | -3.61M | 147K | -3.3K | -22.5K | -633.1K |
Income before tax | -20.94M | -34.73M | -25.58M | -19.20M | -3.72M | -3.81M |
Income tax expense | 0 | 3.45M | 65.6K | 3.3K | 22.5K | 0 |
Net income | -21.29M | -38.18M | -25.65M | -19.20M | -3.75M | -3.81M |
Earnings per share | ||||||
Basic EPS | -21.41 | -70.12 | -67.4 | -79.08 | -29 | -32.4 |
Diluted EPS | -21.41 | -70.12 | -67.4 | -79.08 | -29 | -32.4 |
| Data source | Data source | Data source | Data source |